“As president of SUO, it's really rewarding to be able to hand these giants these great awards,” says Michael S. Cookson, MD, MMHC, FACS.
In this video, the Society of Urologic Oncology’s (SUO) Past President Michael S. Cookson, MD, MMHC, FACS, discusses the achievements of the 2021 SUO Annual Meeting’s award recipients, including those of Curtis A. Pettaway, MD; Gerald L. Andriole Jr, MD; Patrick C. Walsh, MD; and Maria Carmen Mir, MD. Cookson is a professor and chairman of the department of urology and the Donald D. Albers endowed chair in urology at the University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma.
KIM-1 emerges as biomarker for MRD, atezolizumab benefit in renal cell carcinoma
June 3rd 2024Circulating kidney injury molecule-1 (KIM-1) may be a biomarker for minimal residual disease, disease recurrence, and benefit from adjuvant atezolizumab in patients with renal cell carcinoma at increased risk of recurrence, according to a retrospective analysis of the phase 3 IMmotion010 trial.